These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26742993)

  • 21. The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
    Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF
    Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.
    Cazzola M; Rossi M; Malcovati L;
    Blood; 2013 Jan; 121(2):260-9. PubMed ID: 23160465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total synthesis of 6-deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 cancer cell line.
    Arai K; Buonamici S; Chan B; Corson L; Endo A; Gerard B; Hao MH; Karr C; Kira K; Lee L; Liu X; Lowe JT; Luo T; Marcaurelle LA; Mizui Y; Nevalainen M; O'Shea MW; Park ES; Perino SA; Prajapati S; Shan M; Smith PG; Tivitmahaisoon P; Wang JY; Warmuth M; Wu KM; Yu L; Zhang H; Zheng GZ; Keaney GF
    Org Lett; 2014 Nov; 16(21):5560-3. PubMed ID: 25376106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The splicing factor Prp17 interacts with the U2, U5 and U6 snRNPs and associates with the spliceosome pre- and post-catalysis.
    Sapra AK; Khandelia P; Vijayraghavan U
    Biochem J; 2008 Dec; 416(3):365-74. PubMed ID: 18691155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analysis of Hsh155/SF3b1 interactions with the U2 snRNA/branch site duplex.
    Carrocci TJ; Paulson JC; Hoskins AA
    RNA; 2018 Aug; 24(8):1028-1040. PubMed ID: 29752352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.
    Darman RB; Seiler M; Agrawal AA; Lim KH; Peng S; Aird D; Bailey SL; Bhavsar EB; Chan B; Colla S; Corson L; Feala J; Fekkes P; Ichikawa K; Keaney GF; Lee L; Kumar P; Kunii K; MacKenzie C; Matijevic M; Mizui Y; Myint K; Park ES; Puyang X; Selvaraj A; Thomas MP; Tsai J; Wang JY; Warmuth M; Yang H; Zhu P; Garcia-Manero G; Furman RR; Yu L; Smith PG; Buonamici S
    Cell Rep; 2015 Nov; 13(5):1033-45. PubMed ID: 26565915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple U2AF65 binding sites within SF3b155: thermodynamic and spectroscopic characterization of protein-protein interactions among pre-mRNA splicing factors.
    Thickman KR; Swenson MC; Kabogo JM; Gryczynski Z; Kielkopf CL
    J Mol Biol; 2006 Feb; 356(3):664-83. PubMed ID: 16376933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.
    Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellström-Lindberg E
    Br J Haematol; 2015 Nov; 171(4):478-90. PubMed ID: 26255870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement for SLU7 in yeast pre-mRNA splicing is dictated by the distance between the branchpoint and the 3' splice site.
    Brys A; Schwer B
    RNA; 1996 Jul; 2(7):707-17. PubMed ID: 8756413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A UHM-ULM interface with unusual structural features contributes to U2AF2 and SF3B1 association for pre-mRNA splicing.
    Galardi JW; Bela VN; Jeffery N; He X; Glasser E; Loerch S; Jenkins JL; Pulvino MJ; Boutz PL; Kielkopf CL
    J Biol Chem; 2022 Aug; 298(8):102224. PubMed ID: 35780835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broad variation in response of individual introns to splicing inhibitors in a humanized yeast strain.
    Hunter O; Talkish J; Quick-Cleveland J; Igel H; Tan A; Kuersten S; Katzman S; Donohue JP; S Jurica M; Ares M
    RNA; 2024 Jan; 30(2):149-170. PubMed ID: 38071476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin.
    Murthy T; Bluemn T; Gupta AK; Reimer M; Rao S; Pillai MM; Minella AC
    J Biol Chem; 2018 Jun; 293(26):10220-10234. PubMed ID: 29764937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a monoclonal antibody against the mouse Sf3b1 (SAP155) gene product for U2 snRNP component of spliceosome.
    Horie A; Isono K; Koseki H
    Hybrid Hybridomics; 2003 Apr; 22(2):117-9. PubMed ID: 12831537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1).
    Chung FF; Tan PF; Raja VJ; Tan BS; Lim KH; Kam TS; Hii LW; Tan SH; See SJ; Tan YF; Wong LZ; Yam WK; Mai CW; Bradshaw TD; Leong CO
    Sci Rep; 2017 Feb; 7():42504. PubMed ID: 28198434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A central role of Cwc25 in spliceosome dynamics during the catalytic phase of pre-mRNA splicing.
    Tseng CK; Chung CS; Chen HC; Cheng SC
    RNA; 2017 Apr; 23(4):546-556. PubMed ID: 28057857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem-loop 4 of U1 snRNA is essential for splicing and interacts with the U2 snRNP-specific SF3A1 protein during spliceosome assembly.
    Sharma S; Wongpalee SP; Vashisht A; Wohlschlegel JA; Black DL
    Genes Dev; 2014 Nov; 28(22):2518-31. PubMed ID: 25403181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and NMR analyses of an SF3b155-p14-U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing.
    Spadaccini R; Reidt U; Dybkov O; Will C; Frank R; Stier G; Corsini L; Wahl MC; Lührmann R; Sattler M
    RNA; 2006 Mar; 12(3):410-25. PubMed ID: 16495236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Titration of SF3B1 Activity Reveals Distinct Effects on the Transcriptome and Cell Physiology.
    Kim Guisbert KS; Mossiah I; Guisbert E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia.
    Wang C; Sashida G; Saraya A; Ishiga R; Koide S; Oshima M; Isono K; Koseki H; Iwama A
    Blood; 2014 May; 123(21):3336-43. PubMed ID: 24735968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
    Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
    J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.